Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia

Gynecologic Oncology

Volumn 104, Issue 2, 2007, Pages 290-295

  Villavicencio, A ^a,b   Bacallao, K ^a   Gabler, F ^a   Fuentes, A ^a   Albornoz, J ^c   Casals, A ^a   Vega, M ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Apoptosis related proteins; Endometrium; Ki67; Polycystic ovarian syndrome

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DNA DETERMINATION; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL GROWTH PROCESSES; DNA FRAGMENTATION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; POLYCYSTIC OVARY SYNDROME; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33846379267     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.09.003     Document Type: Article

References (36)

1. Shiozawa T., Li S., Nakayama K., et al. Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol. Hum. Reprod. 2 (1996) 745-752
2. Sagle M., Bishop K., Ridley N., et al. Recurrent early miscarriage and polycystic ovaries. BMJ 297 (1998) 1024-1026
3. Regan L., Owen E.J., and Jacobs H.S. Hypersecretion of luteinizing hormone, infertility, and miscarriage. Lancet 336 (1990) 1141-1144
4. Tulppala M., Stenman U.H., Cacciatore B., et al. Polycystic ovaries and levels of gonadotrophins and androgen in recurrent miscarriage: prospective study in 50 women. Br. J. Obstet. Gynaecol. 100 (1993) 348-352
5. Balen A. Polycystic ovary syndrome and cancer. Hum. Reprod. Updat. 7 (2001) 522-525
6. Hardiman P., Pillay O.C., and Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 361 (2003) 1810-1812
7. Gadducci A., Gargini A., Palla E., et al. Polycystic ovary syndrome and gynecological cancers: is there a link?. Gynecol. Endocrinol. 20 (2005) 200-208
8. Pillay O.C., Te Fong L.F., Crow J.C., et al. The association between polycystic ovaries and endometrial cancer. Hum. Reprod. 21 (2006) 924-929
9. Chamlian D.L., and Taylor H.B. Endometrial hyperplasia in young women. Obstet. Gynecol. 36 (1970) 659-666
10. Cheung A.P. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet. Gynecol. 98 (2001) 325-331
11. Gompel A., Sabourin J.C., Martin A., et al. Bcl-2 expression in normal endometrium during the menstrual cycle. Am. J. Pathol. 144 (1994) 1195-1202
12. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
13. Tao X.J., Tilly K.I., Maravei D.V., et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J. Clin. Endocrinol. Metab. 82 (1997) 2738-2746
14. Maliqueo M., Clementi M., Gabler F., et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil. Steril. 80 Suppl. 2 (2003) 812-819
15. Nakamura T., Nomura S., Sakai T., et al. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Hum. Pathol. 28 (1997) 309-315
16. Kokawa K., Shikone T., Otani T., et al. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum. Reprod. 16 (2001) 2211-2218
17. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
18. Budihardjo I., Oliver H., Lutter M., et al. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
19. Di Paola M., Loverro G., Caringella A.M., et al. Receptorial and mitochondrial apoptotic pathways in normal and neoplastic human endometrium. Int. J. Gynecol. Cancer 15 (2005) 523-528
20. Morsi H.M., Leers M.P., Pager W., et al. The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometrium. Int. J. Gynecol. Pathol. 19 (2000) 118-126
21. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19 (2004) 41-47
22. Kurman R.J., Kaminski P.F., and Norris H.J. The behaviour of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
23. Noyes R.W., Hertig D.T., and Rock J. Dating the endometrial biopsy. Fertil. Steril. 1 (1950) 3-25
24. Castro A., Johnson M.C., Anido M., et al. Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil. Steril. 78 (2002) 587-595
25. Coulam C.B., Annegers J.F., and Kranz J.S. Chronic anovulation syndrome and associated neoplasia. Obstet. Gynecol. 61 (1983) 403-407
26. Legro R.S. Polycystic ovary syndrome: the new millenium. Mol. Cell. Endocrinol. 184 (2001) 87-93
27. ACOG practice bulletin. Polycystic ovary syndrome. Obstet. Gynecol. 100 (2002) 1389-1402
28. Carmina E., and Lobo R.A. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J. Clin. Endocrinol. Metab. 84 (1999) 1897-1899
29. Ehrmann D.A. Polycystic Ovary Syndrome. N. Engl. J. Med. 352 (2005) 1223-1236
30. Critchley H.O., Tong S., Cameron S.T., et al. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J. Reprod. Fertil. 115 (1999) 389-395
31. Adachi M., and Tsujimoto Y. Potential Z-DNA elements surrounded the breakpoints of chromosome translocation within the 5′ flanking region of bcl-2 gene. Oncogene 5 (1990) 1653-1657
32. Vaskivuo T.E., Stenback F., and Tapanainen J.S. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer 95 (2002) 1463-1471
33. Niemann T.H., Trgovac T.L., McGaughy V.R., et al. bcl-2 expression in endometrial hyperplasia and carcinoma. Gynecol. Oncol. 63 (1996) 318-322
34. Vaskivuo T.E., Stenback F., Karhumaa P., et al. Apoptosis and apoptosis-related proteins in human endometrium. Mol. Cell. Endocrinol. 165 (2000) 75-83
35. Mertens H.J., Heineman M.J., and Evers J.L. The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecol. Obstet. Invest. 53 (2002) 224-230
36. Maliqueo M., Quezada S., Clementi M., et al. Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells. Reprod. Biol. Endocrinol. 2 (2004) 1-10